Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
We have previously reported suggestive linkage of type 2 diabetes mellitus to chromosome 10q. We genotyped 228 microsatellite markers in Icelandic individuals with type 2 diabetes and controls throughout a 10.5-Mb interval on 10q. A microsatellite, DG10S478, within intron 3 of the transcription factor 7-like 2 gene (TCF7L2; formerly TCF4) was associated with type 2 diabetes (P = 2.1 x 10(-9)). This was replicated in a Danish cohort (P = 4.8 x 10(-3)) and in a US cohort (P = 3.3 x 10(-9)). Compared with non-carriers, heterozygous and homozygous carriers of the at-risk alleles (38% and 7% of the population, respectively) have relative risks of 1.45 and 2.41. This corresponds to a population attributable risk of 21%. The TCF7L2 gene product is a high mobility group box-containing transcription factor previously implicated in blood glucose homeostasis. It is thought to act through regulation of proglucagon gene expression in enteroendocrine cells via the Wnt signaling pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The majority of associated loci are linked to beta cells, supporting the idea that impaired beta cell function is critical to type 2 diabetes pathogenesis78,80.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“The first associated loci, in genes including TCF7L2, INSR, IRS1, GCK and KCNJ11 (refs.77,78), were originally identified by linkage or candidate gene studies, and since the turn of the century, increasing size and depth of genome-wide association studies have rapidly expanded the list of associated loci in type 2 diabetes to more than 250 with 400 independent signals79.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“unequivocal replications are so far limited to variants in just three genes: PPARG, KCNJ11 and TCF7L2 (2-4).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [4]
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“The prevalence of type 2 diabetes worldwide is 6% but is projected to rise over the next decade owing to increasing age of the population and surge of obesit”
BackgroundConvergence of Wnt, ß-Catenin, and Cadherin Pathways
Nelson, W. J., & Nusse, R. (2004) · Science · doi:10.1126/science.1094291 · Cited by 2,515 · cited 1×
“The β-catenin protein is also important for mediating cell adhesion through its binding of cadherin”
BackgroundThe common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4
Korinek, V., Barker, N., Moerer, P., van Donselaar, E., Huls, G., Peters, P. J., & Clevers, H. (1998) · Nature Genetics · doi:10.1038/1270 · Cited by 1,581
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E. H., et al. (2000) · Nature Genetics · doi:10.1038/79876 · Cited by 1,468
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123 · cited 1×
“Similar to TCF7L2 , five of the six positionally cloned genes for the rare mendelian forms of type 2 diabetes, maturity-onset diabetes of the young (MODY), are transcription factor”
BackgroundAllele-Sharing Models: LOD Scores and Accurate Linkage Tests
Kong, A., & Cox, N. J. (1997) · The American Journal of Human Genetics · doi:10.1086/301592 · Cited by 979
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Cited by
Items 1,001–1,004 of 1,004
Barabash, A., Valerio, J. D., Garcia de la Torre, N., Jimenez, I., del Valle, L., Melero, V., Assaf-Balut, C., Fuentes, M., Bordiu, E., Durán, A., et al. (2020) · Metabolism Open · doi:10.1016/j.metop.2020.100069 · Cited by 18
Pharmacogenetics: potential role in the treatment of diabetes and obesity
Vella, A., & Camilleri, M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.7.1109 · Cited by 17
“While variation in KCNJ11 may alter insulin secretion and variation in PPARG may alter insulin action [30] , the mechanisms by which the disease-associated variation in TCF7L2 causes diabetes is unknown.”
BackgroundInfluentialInherited β-Cell Dysfunction in Lean Individuals With Type 2 Diabetes
Mathews, A. E. W., & Mathews, C. E. (2012) · Diabetes · doi:10.2337/db12-0373 · Cited by 14
“TCF7L2 is one of the most significant loci for type 2 diabetes (5) and, along with HNF1B/HNF4A (6) and KCNJ11 (7), tie genes involved in b-cell dysfunction to risk for developing type 2 diabetes in overweight individuals.”
BackgroundCheng, C.-Y., Reich, D., Haiman, C. A., Tandon, A., Patterson, N., Elizabeth, S., Akylbekova, E. L., Brancati, F. L., Coresh, J., Boerwinkle, E., et al. (2012) · PLoS ONE · doi:10.1371/annotation/52e53d8e-a4bd-4419-951a-75ddcbaf6c5d · Cited by 2
Metadata
- Authors
- Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., Styrkarsdottir, U., Magnusson, K. P., Walters, G. B., Palsdottir, E., Jonsdottir, T., Gudmundsdottir, T., Gylfason, A., Saemundsdottir, J., Wilensky, R. L., Reilly, M. P., Rader, D. J., Bagger, Y., Christiansen, C., Gudnason, V., Sigurdsson, G., Thorsteinsdottir, U., Gulcher, J. R., Kong, A., & Stefansson, K.
- Affiliations
- deCODE Genetics (Iceland) (IS)
- National University Hospital of Iceland (IS)
- University of Pennsylvania (US)
- Center for Clinical & Basic Research (DK)
- Icelandic Heart Association (IS)
- Corresponding author
- Grant, Struan F A
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-01-15
- Volume
- 38
- Issue
- 3
- Pages
- 320-323
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1965141016
- Cited by
- 2,287
- References
- 25
- Citations by year
- 2026: 45 · 2025: 58 · 2024: 54 · 2023: 56 · 2022: 80 · 2021: 86 · 2020: 76 · 2019: 86 · 2018: 86 · 2017: 85 · 2016: 99 · 2015: 109 · 2014: 125 · 2013: 125 · 2012: 156
- FWCI
- 127.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- University of Pennsylvania
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 2 diabetes, TCF7L2, transcription factor 7-like 2, chromosome 10q, genetic susceptibility, blood glucose homeostasis, Wnt signaling, Icelandic population, Danish population, United States population
- MeSH terms
- Chromosome Mapping, Chromosomes, Human, Pair 10, Denmark, Diabetes Mellitus, Type 2, Gene Frequency, Genetic Carrier Screening, Humans, Introns, Molecular Sequence Data, Reference Values, Cohort Studies, Microsatellite Repeats, Genetic Predisposition to Disease, TCF Transcription Factors, Transcription Factor 7-Like 2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.